FridayMay 06, 2022 1:31 pm

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris Supporting Collaboration in the Most Efficient, Effective Way Possible

Nowigence shines in knowledge management, a category Gartner Inc. forecasts will be one of the top five use case categories for AI software spending in 2022. “The company’s Pluaris offering is a personal knowledge management (‘PKM’) tool that generates an annotated data feed based on topics of interest and then automatically creates a permanent personal knowledge base from a specified feed and private uploads. The app works around the clock and can analyze hundreds of pages of text almost instantly,” a recent article reads. “With its Pluaris offering, Nowigence provides a unique solution to the growing challenge of collaboration overload…

Continue Reading

FridayMay 06, 2022 1:17 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to satisfy demand in the state. “The debut marks RWB’s line expansion into the higher-margin live resin vapes segment and also represents its inaugural product in Michigan beyond the popular distillate vape products. The company is committed to releasing many more products in the future,” a recent article reads. “Red White & Bloom expects PV Live Resin to become popular with consumers owing to the trust…

Continue Reading

FridayMay 06, 2022 12:58 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Moving to Become One of the Largest Payments Facilitators on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, participated in the recently concluded NobleCon18 – Noble Capital Markets’ 18th Annual Investor Conference that took place at the Hard Rock Hotel, Hollywood, Florida. “Bitcoin’s Lightning Network is continuing to see explosive growth. LQwD is benefiting from this growth as we continue to strategically expand our Lightning Network presence through the launch of our global routing nodes to become one of the largest payments facilitators on the network,” LQwD CEO Shone Anstey commented before the event. According to a…

Continue Reading

FridayMay 06, 2022 12:36 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) System Offering Independence from Widely Fluctuating Supply Chain

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is helping build robust and decentralized food systems through its green ammonia production solution. The technology, which generates green ammonia from sustainable electricity, air and water, eliminates carbon dioxide emissions linked to the industrial production of anhydrous grey ammonia. The system also reduces the agricultural sector’s carbon footprint related to fertilizer production and distribution – the sector uses about 80% of the ammonia produced annually to satisfy its fertilizer needs. “In addition to reducing CO2 emissions, the FuelPositive system decentralizes ammonia production, freeing farmers from supply chain shocks, as is the case currently. In fact,…

Continue Reading

FridayMay 06, 2022 11:38 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases New Lightning Network Node in India, Leveraging Growth of Cryptocurrency Use in the Area

The global cryptocurrency market is expected to grow at a CAGR of 12.8%, to reach US $4.94 billion by 2030 The increase in cryptocurrency adoption worldwide has shown explosive market growth and the increased need for transaction facilitation like LQwD's PaaS protocol on the Lightning Network India ranks number two in the adoption and use of cryptocurrency Experts in the cryptocurrency industry estimate that India has more than 20 million crypto investors, with most growth being driven by users under the age of 35 LQwD currently has 10 active nodes on the Lightning Network with a capacity of over 10…

Continue Reading

FridayMay 06, 2022 11:12 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and operating results for its fiscal year ended Dec. 31, 2021. During the webcast, Flora’s management will deliver comments on financial results, operational highlights from 2021, as well as share a brief look at the company’s performance in 2022 thus far. Following the presentation, analysts, media and investors will be afforded the opportunity to ask questions in a Q&A session. Interested parties may join the webcast…

Continue Reading

FridayMay 06, 2022 9:00 am

The 2nd Annual Gene Therapy Summit To Share Insights On Safer Gene Therapy Programs

The 2nd Annual Gene Therapy Summit will take place June 7-9, 2022, in Boston, MA. With a focus on effectively engaging genetic therapy patients, this is a must attend summit for individuals and companies that are serious about building safer and more meaningful gene therapy programs. The summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of patient engagement in genetic therapy and will generate actionable insights through detailed case studies and open discussions.  As gene therapies proliferate and sector investment continues to…

Continue Reading

FridayMay 06, 2022 9:00 am

Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial

Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause of mental disability worldwide Preclinical studies show CYB003 may have significant advantages over classic psilocybin In a significant step forward in the study of alternative treatments for major depressive disorder, Cybin (NEO: CYBN) (NYSE American: CYBN) is moving forward in its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003 (https://ibn.fm/VTjoI). Based on previous research, CYB003 has the potential to effectively treat MDD with significant…

Continue Reading

FridayMay 06, 2022 9:00 am

Kronos Advanced Technologies Inc. (KNOS) Venturing into Metaverse with Initial eCommerce Virtual Store

“Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article Kronos is one of the earliest companies to design and soon open its own metaverse virtual store Emergen Research reports that metaverse market reached $47.69 billion in 2020, by 2028 could see a revenue CAGR of 43.3% The metaverse is everywhere, popping up in entertainment and vying for news headlines. This immersive virtual world where people live, work, shop and interact through avatars once seemed like science fiction but is fast becoming a real-world fact. Savvy companies, including Kronos Advanced Technologies…

Continue Reading

ThursdayMay 05, 2022 3:00 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma multiforme (“GBM”). On average, GBM is nearly 100% fatal just over a year into diagnosis. “CNS announced that France’s regulatory agencies have granted the company authority to pursue patient recruitment in the country…. France’s approval comes on the heels of similar authorization in Switzerland, where Swissmedic, the Swiss agency for therapeutic products, joined swissethics, the umbrella organization of the cantonal Ethics Committees (‘ECs’), in greenlighting…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered